Increased Cancer Risk Associated with Treatment for Diabetic Leg and Foot Ulcers

March 28, 2008

The FDA is conducting a safety review based on study data suggesting there may be an increased risk of death from cancer in diabetic patients using Regranex (becaplermin) Gel, a skin product used to heal leg and foot ulcers. While the review is ongoing, the FDA recommends health care professionals discuss the potential risks and benefits of using Regranex with their patients.

Popularity: 69% [?]

Share:

Posted by PharmaWatchDog | Filed Under Prescription Drugs, Regranex | 2 Comments

Subscribe to the
PharmaWatchDog Newsletter

by Entering Your Email Address:
Information On
- Consumer Fraud (3)
- Environment Contaminates (9)
  - FEMA Trailers (2)
  - Nanotechnology (2)
    - Nanotubes (1)
  - Pesticides (1)
  - Pharmaceuticals (2)
  - Posts with Video (1)
  - Trichloroethylene (1)
- Health News (17)
- Medical Devices (9)
  - Alaris Pump Module (1)
  - Catheters (1)
  - Endovascular Grafts (1)
  - Fractured Heart Leads (1)
  - Hearing Aids (1)
  - Plastic Stents (1)
  - Prodisc (1)
  - SynchroMed EL (1)
- Other Products (42)
  - Degreasing Agent (1)
  - Denture Cleansers (1)
  - FEMA Trailers (2)
  - Icy Hot Heat Therapy (2)
  - Nanotechnology (2)
  - Nutritional Supplements (8)
  - Plastics (1)
  - Posts with Video (1)
  - Tobacco (1)
- Prescription Drugs (44)
  - Actiq (1)
  - Antiepileptic Drugs (1)
  - Avandia (2)
  - Botox (1)
  - Byetta (1)
  - Cardizem (1)
  - CellCept (1)
  - Chantix (3)
  - Colchicine (1)
  - Duragesic (2)
  - Erectile Dysfunction (2)
  - Erythropoiesis Stim. Agts (1)
  - Exjade (1)
  - Fentora (1)
  - Heparin (3)
  - Hormone Replacement Therapy (2)
  - Leukine (2)
  - Posts with Video (1)
  - Prezista (1)
  - Provigil (1)
  - Regranex (1)
  - Spiriva (1)
  - Statins (1)
  - Tamiflu (1)
  - Trasylol (1)
  - Tussionex (1)
  - Tysabri (1)
  - Vaccines (2)
  - Vioxx (2)
  - Vytorin (2)
  - Zyprexa (1)